Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 11Unknown 4Terminated 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Polycystic Ovary Syndrome 2Uterine Cervical Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Hyperbilirubinemia 1Arthritis, Rheumatoid 1

Interventions

Metformin 7Clomiphene 4Progesterone 2Pioglitazone 2Medroxyprogesterone Acetate 2Inositol 2Folic Acid 2Flutamide 2Estrogens 2Estradiol 2salicylsalicylic acid 1ganirelix 1Thioctic Acid 1Sugars 1Resistance Training 1Raloxifene Hydrochloride 1Progestins 1Nutrition Assessment 1Methyltestosterone 1Magnesium 1Linseed Oil 1Leuprolide 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Itraconazole 1Gonadotropins 1Flour 1Fenofibrate 1Exercise 1Docosahexaenoic Acids 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Polycystic Ovary Syndrome × Folic Acid × Clear all
NCT04881851 2025-04-16

IALA

Universita di Verona

Phase NA Terminated
76 enrolled

Polycystic Ovary Syndrome

NCT02221154 2017-06-16

FIV-INOPK

Centre Hospitalier Departemental Vendee

Phase 4 Terminated
49 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡